Frederick David

Title: Frederick David: Innovator in Antimicrobial Pharmaceutical Compositions

Introduction

Frederick David is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial preservatives. His innovative work focuses on enhancing the efficacy of liquid dosage forms through the use of beta-cyclodextrins.

Latest Patents

Frederick David holds a patent for "Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms." This invention is directed to pharmaceutical compositions that contain a therapeutically effective amount of an Active Pharmaceutical Ingredient (API), a pharmaceutically acceptable cyclodextrin, and a pharmaceutically acceptable preservative. The invention also encompasses pharmaceutical compositions of compounds where R is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl, and tert-butyl, along with a suitable cyclodextrin and preservative.

Career Highlights

Throughout his career, Frederick David has worked with prominent companies in the pharmaceutical industry, including Pfizer Products Inc. and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical formulations.

Collaborations

Frederick has collaborated with notable colleagues such as Julia Ann Wood and Roger C Adami. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Frederick David's work in antimicrobial pharmaceutical compositions showcases his dedication to innovation in the field. His contributions have the potential to significantly impact the effectiveness of liquid dosage forms in the pharmaceutical industry.